Altria Group Inc. released its latest quarterly earnings, sparking interest among investors and analysts alike. The company's profit margin surpassed expectations, leading to a fluctuating market reaction. Key factors contributing to this outlook include shifting consumer preferences. The future

The FDA has issued a warning about the risks of smuggled tirzepatide as the peptide therapeutics market grows rapidly. The market is expected to jump from $38 billion in 2023 to $106 billion by 2033, with an impressive 10.8% compound annual growth rate. Legitimate peptide medications have copyright